Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02068079
Title A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Duke University
Indications

melanoma

Therapies

Trientine + Vemurafenib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST